Maarten Lambrecht (@mlambr1) header
Maarten Lambrecht (@mlambr1) profile picture

Radiation Oncologist

Louvain, Belgium
Joined January 2012
Maarten Lambrecht retweeted
S1914: Adding immunotherapy to SBRT did NOT improve outcomes in early-stage NSCLC 🚫 Phase III SWOG/NRG S1914 High-risk, early-stage, medically inoperable NSCLC 402 eligible patients • Atezolizumab + SBRT: 201 • SBRT alone: 201 • Atezolizumab 1200 mg q3w, up to 8 cycles • SBRT started with cycle 3 📊 Updated efficacy 2-year PFS • Atezo + SBRT: 66% • SBRT: 67% • HR 0.93 (95% CI 0.66–1.31) 2-year OS • Atezo + SBRT: 82% • SBRT: 82% • HR 1.04 (95% CI 0.69–1.58) ⚠️ More toxicity Grade ≥3 treatment-related AEs: • Atezo + SBRT: 12% • SBRT: 3% Two grade 5 respiratory events occurred with atezolizumab + SBRT. The trial closed early for futility. 🔑 Take-home: For unselected patients with early-stage inoperable NSCLC, adding peri-SBRT atezolizumab increased toxicity without improving PFS or OS. SBRT alone remains the standard of care. @SWOG @NRGonc @TheLancetOncol @oncoalert #LCSM #NSCLC #RadiationOncology #Immunotherapy
6
22
57
4,415
Maarten Lambrecht retweeted
Placebo Controlled Randomized Trial: Memantine given w/Brain RT Improved Cognitive Outcomes & QOL 1/3 sciencedirect.com/science/ar…
3
29
1
66
3,793
Maarten Lambrecht retweeted
Cognition sparing SRS compared to N0574/N107C SRS COG-SRS better all-domains cognitive outcomes, especially language #ASTRO26 abstract #280 sciencedirect.com/science/ar…
1
12
29
1,905
Maarten Lambrecht retweeted
Great @EANOassociation @ESTRO_RT #Roma2026 session on cognitive-sparing radiotherapy chaired by Jona Hattangadi-Gluth and Anthony Chalmers. Thanks to all the speakers for their outstanding talks and discussion! #EANO2026
4
11
480
Maarten Lambrecht retweeted
🚨🚨 Randomized Trial #ASTRO26 Resected Brain Met fractionated SRS vs single fraction SRS post-op cavity 🚨 • fSRS superior surgical bed control • No diff AEs • fSRS standard of care for resected larger brain met
8
66
4
161
11,188
Maarten Lambrecht retweeted
🚨🚨Randomized Trial #ASTRO26 Small Cell Lung Cancer Brain Met fractionated SRS vs HA-WBRT 🚨 • No diff time to cognitive failure, neurologic death • SRS ↑↑ OS • ↑↑ AEs HA-WBRT • SRS standard of care SCLC brain met
5
84
9
188
18,294
Maarten Lambrecht retweeted
Radiotherapy after surgery halves risk of recurrence in a type of brain tumour that can often grow back, trial shows. Find out more in The Lancet: spkl.io/60137TUFS #EANO2026
7
54
2
144
30,316
Tour de force presentation by my former mentor @michelle_monje for the Abhijit Guha Award and Lecture! #SNO2024 #cancerneuroscience
2
24
1,563
Maarten Lambrecht retweeted
Brain network topology and its cognitive impact in adult glioma survivors, from @LaurienDeRoeck, @mlambr1, @CharlotteSleurs, @treanus, Jeroen Blommaert, and Patrick Dupont nature.com/articles/s41598-0…
2
5
1,415
Maarten Lambrecht retweeted
📢 our latest research published in @Nature Sci Rep 🧠 rdcu.be/dJR8B Our study reveals how structural brain network metrics are altered in glioma survivors and how these changes are linked to cognitive functions. @mlambr1 @CharlotteSleurs @treanus
1
1
4
195
Maarten Lambrecht retweeted
What a great day at @ESTRO_RT! An honor to present our results on the role of structural hubs in cognition and the association with RT dose 🧠 @FWOVlaanderen @gminniti2012 #radonc #connectome
2
1
14
1,051
Maarten Lambrecht retweeted
Donal Hollywood award winner at #ESTRO24 @piet_ost for the STORM trial Congrats to @ZilliThomas and all contributors 👏
1
28
1
105
5,661
Maarten Lambrecht retweeted
New study🚨Out on @NatureComms unveils #HIFI, a groundbreaking spatial proteomic technique🧬, shedding light on diverse responses to radiation therapy☢️ in brain tumors ✅#glioblastoma 🧠undergoes significant spatial reorganization post-treatment, contrasting with brain metastasis. nature.com/articles/s41467-0… @DrSpencerWatson, @BenoitDuc2, @ZiqiKang2000, @NilsEling, @massara_matteo, @jeanhausser & @Johanna_A_Joyce #OncoAlertAF @nataliagandur @acampsmalea @MartaPerachino @heinrich_kat @BiagioRicciutMD @DenizCanGuven1 @yekeduz_emre @HHorinouchi @FadiHaddad_MD @Dr_Ivanoncologo @Abdallah81MD @FernandoOnco @ElisaAgostinett @dr_yakupergun @to_be_elizabeth
11
31
4,987
Maarten Lambrecht retweeted
Replying to @drdavidpalma
Adding to the congratulory comments @drdavidpalma. Your leadership and insight in this trial and space is tremendous. Looking forward to seeing results from this Herculean effort. – at Rancho Santa Margarita, CA
1
3
745
Maarten Lambrecht retweeted
Oh well. Case closed. 😂 @toddscarbrough
Pencil beam scanning proton therapy for pregnant patients with brain and head and neck cancers Link at: redjournal.org/article/S0360…
37%Yes, this is the new SOC
13%No, it's retro dosimetry
32%I do not discuss protons
19%Why radiate this person
63 votes • Final results
1
2
6
2,896
Maarten Lambrecht retweeted
#ASTRO2023 Assessment of Precision RT in Early NSCLC and ILD (ASPIRE-ILD) presented by @drdavidpalma 👉 OS at 1-year 78.9%, median OS 25 months 👉 AE event: grade 3 n=4 (10%), grade 4 n=0, grade 5 n=3 (7.7%) 👍 Primary endpoint met, SBRT valid option in overall high-risk pts
17
2
44
6,303
Maarten Lambrecht retweeted
#ASTRO2023 High Dose Hyperfractionated Thoracic RT vs. Standard Dose for LS SCLC: Randomized Phase 3 Trial 45Gy in 30 FX vs 54Gy in 30FX 👉 Substantial difference in OS, smaller but significant in PFS 👉 Similar toxicity ❓ Difference in effect size OS vs PFS ❓ Pt selection
13
41
3,006
Maarten Lambrecht retweeted
In UZ Leuven werd voor het eerst een patiënt op het hart bestraald om levensbedreigende ritmestoornissen te verhelpen. Prof. @EctorJoris: "De samenwerking tussen cardiologen en radiotherapeuten biedt onze patiënten een bijkomende behandelingsoptie." 👉 https://teapaw.org/t.co/jN8pr9bhD0
2
8
18
1,910
Maarten Lambrecht retweeted
Single fraction 8Gy vs SBRT 20Gy for painful bone mets, n=126, mostly non-spine #ESTRO23 Complete pain response at 1 mo primary endpoint 👉 no difference at 1 mo 👉 improved in per protocol analysis after 3mo 👉 no increased toxicity PATIENT SELECTION IS KEY
6
63
3
132
11,815